Guidance, NICE advice and quality standards in development

Showing 1 to 10 of 372

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]	Technology appraisal guidance	TBC
Abaloparatide for treating osteoporosis in postmenopausal women [ID882]	Technology appraisal guidance	TBC
Abatacept for preventing moderate to severe acute graft-versus-host disease after haematopoietic stem cell transplant in people 6 years and over [ID6185]	Technology appraisal guidance	TBC
Abicipar pegol for treating wet age-related macular degeneration ID1533	Technology appraisal guidance	TBC
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]	Technology appraisal guidance	TBC
Acute kidney injury: prevention, detection and management - Assessing risk factors for acute kidney injury in adults having iodine-based contrast media	NICE guideline	TBC
Adrenal insufficiency: acute and long-term management	NICE guideline	14 August 2024
Alcohol-mediated perivascular renal denervation for resistant hypertension	Interventional procedures guidance	9 December 2024
Algorithm-based remote monitoring of heart failure risk data in people with cardiac implantable electronic devices	Diagnostics guidance	22 August 2024
ALXN1840 for treating Wilson disease TS ID 9950	Technology appraisal guidance	TBC